COMMUNIQUÉS West-GlobeNewswire

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/05/2026
RESEARCH TRIANGLE PARK, N.C., May 18, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on May 11, 2026, [...]
Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference
18/05/2026
BURLINGTON, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system [...]
Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
18/05/2026
– Oral presentation highlights efficacy and safety profile of lorundrostat in patients with uncontrolled hypertension and chronic kidney disease – RADNOR, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, [...]
Capitol Hill Briefing To Spotlight Critical Health Care Services for Adults With Communication Disorders
18/05/2026
ASHA Collaborates With Co-Chairs of the Unified Voices Caucus, Reps. Kat Cammack and Troy Carter, for May 20 Event Rockville, Md., May 18, 2026 (GLOBE NEWSWIRE) -- In recognition of National Speech-Language-Hearing [...]
Ipsen - Avril 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
18/05/2026
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Carbios announces a change in its governance and the appointment of Benoît Grenot as Chief Executive Officer
18/05/2026
Clermont-Ferrand (France), May 18, 2026 (5:45 p.m. CEST). Carbios (Euronext Growth Paris: ALCRB) announces an evolution of its governance. At the age of 64, and having expressed his wish to retire, Vincent Kamel will [...]
Letter to Shareholders from CEO Dr. Ryan Saadi
18/05/2026
WARREN, N.J., May 18, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ). Dear Shareholders, Since Tevogen’s 2024 public listing, we have remained focused on building a [...]
NADP: provider, patient benefits rose; dental plan enrollment fell in 2024
18/05/2026
Affordability pressures drive shift toward voluntary plans DALLAS, May 18, 2026 (GLOBE NEWSWIRE) -- Despite a 2024 dip in U.S. dental plan enrollment, dental benefits companies increased payments per member to dental [...]
Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference
18/05/2026
– Verekitug led to statistically significant and clinically meaningful improvement in asthma symptom control as measured by the Asthma Control Questionnaire-6 (ACQ-6) in participants with CRSwNP and comorbid asthma – – [...]
Carbios annonce une évolution de sa gouvernance et la nomination de Benoît Grenot en qualité de Directeur Général.
18/05/2026
Clermont-Ferrand (France), 18 mai 2026 (17h45 CEST). Carbios (Euronext Growth Paris : ALCRB) annonce une évolution de sa gouvernance. Ayant à 64 ans fait part de sa volonté de partir à la retraite, Vincent Kamel [...]
Ipsen - April 2026- Monthly information relative to the total number of voting rights and shares composing the share capital
18/05/2026
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026
18/05/2026
May 18, 2026 From imaging to AI-enabled guidance, Philips connects technologies into a unified workflow to improve efficiency, reduce radiation exposure and support procedural confidence Amsterdam, the Netherlands – As [...]
Disclosure of transparency notifications from BlackRock, Inc.
18/05/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 18 May 2026 – 6 PM CET Disclosure of transparency notifications from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of [...]
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
18/05/2026
Israeli Ministry of Health approved the initiation of Silexion's Phase 2/3 clinical trial of SIL204 in locally advanced pancreatic cancer Clinical Trial Application subsequently submitted to Germany through the EU [...]
Kyverna Therapeutics Names Greg Martini as Chief Financial Officer
18/05/2026
Veteran biopharma leader joins to help lead Kyverna’s next phase of commercial growth EMERYVILLE, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical [...]
Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact
18/05/2026
New analysis from the IMPACT-TD Registry confirms tardive dyskinesia (TD) causes a significant burden for most individuals with concomitant mood disorders, impacting their lives regardless of age The data shows that 85 [...]
New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA’s Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo
18/05/2026
Multicenter prospective RCT published in JAAD confirms superiority of XTRAC® Excimer Laser plus oral JAK inhibitors over tacrolimus combination therapy in children aged 2–18 years with progressive vitiligo, fueling [...]
BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease
18/05/2026
Last Patient Evaluation Visit Completed with Topline Data Release Targeted Q3-2026 CARSON CITY, Nev., May 18, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company [...]
FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics
18/05/2026
HOUSTON, May 18, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending focused on the development of therapeutics [...]

Pages